Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | GlobalData Reports | US Cardiac Rhythm Management Devices Market: Strategic Market Analysis and Insight to 2015

US Cardiac Rhythm Management Devices Market: Strategic Market Analysis and Insight to 2015

Summary

GlobalData’s “US Cardiac Rhythm Management Devices Market: Strategic Market Analysis and Insight to 2015” report is an essential source of data and analysis on the US cardiac rhythm management devices market with complete coverage by categories and segments. The report provides market landscape, competitive landscape and market trends information on three market categories – cardiac resynchronisation therapy, implantable cardioverter defibrillator and pacemaker. The report identifies the key trends shaping and driving the dynamism in the US cardiac rhythm management devices market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the US cardiac rhythm management devices market.

Scope

-The report provides market size data and information on three US cardiac rhythm management devices market categories – Cardiac Resynchronisation Therapy, Implantable Cardioverter Defibrillator and Pacemaker.

-Annualized market revenues data from 2001 to 2008, forecast forward for 7 years to 2015.

-Analysis and review of the key events and milestones that will impact the future of the US cardiac rhythm management devices market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.

-Insightful review of key industry drivers, restraints and challenges which are likely to impact the US cardiac rhythm management devices market in the long run.

-In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.

-The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

-Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.

-Key topics covered include the M&A landscape and the impact of the economic downturn on the US cardiac rhythm management devices market.

-The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

-Develop business strategies by understanding the trends shaping and driving the US cardiac rhythm management devices Market.

-Design and develop your product development, marketing and sales strategies by identifying the market categories poised for a strong growth.

-Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.

-Identify key players best positioned to take advantage of the market opportunities by developing insight on the prevalent and anticipated competitive landscape.

-Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the US cardiac rhythm management devices market in future.

-Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline.

-Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

-What’s the next being thing in the US cardiac rhythm management devices technology landscape? – Identify, understand and capitalize.Pages: 40Publication Date: 2009 MarchCardiovascular Devices, Cardiac Rhythm Management, Pacemaker, Defibrillator
Table of Contents
Price: $3,500.00 / €2,339.40

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions